ステージIII結腸直腸癌に対するランダム化第III相補助療法試験

基本情報

NCT ID: NCT00209742
ステータス: 不明
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 340
治験依頼者名: Hokkaido Gastrointestinal Cancer Study Group

概要

A randomized controlled study is conducted on patients with histological stage III colorectal cancer assigned to postoperative adjuvant therapy of uracil-tegafur plus leucovorin (UFT+LV), UFT+LV / UFT, or UFT+LV+PSK / UFT+PSK. The usefulness of the three regimens was evaluated by comparing the disease-free survival rate, overall survival rate, incidence and severity of adverse event, and quality of life.

対象疾患

Colorectal Cancer

介入

UFT(DRUG)

USEL/Leucovorin(DRUG)

Krestin(DRUG)

依頼者（Sponsor）

Hokkaido University Hospital(OTHER)

Hokkaido Gastrointestinal Cancer Study Group(OTHER)

実施施設 (1)

北海道大学病院

Sapporo, Hokkaido, Japan